Core Viewpoint - China National Chemical Engineering Co., Ltd. (China Chemical) has shown mixed financial performance with a slight increase in revenue and profit, while its financing activities indicate a low level of investor confidence as reflected in the financing balance and stockholder changes [1][2][3]. Financing Summary - On December 19, China Chemical's financing buy-in amounted to 22.93 million yuan, while financing repayment was 35.66 million yuan, resulting in a net financing outflow of 12.73 million yuan [1]. - The total financing and securities balance for China Chemical reached 1.748 billion yuan, which is 3.73% of its market capitalization, indicating a low financing balance compared to the past year [1]. - The company had a high securities lending balance with 120,300 shares remaining, valued at 926,300 yuan, which is above the 60th percentile of the past year [1]. Financial Performance Summary - As of September 30, China Chemical reported a total of 1.35845 billion yuan in revenue for the first nine months of 2025, reflecting a year-on-year growth of 1.26% [2]. - The net profit attributable to shareholders for the same period was 4.232 billion yuan, showing a year-on-year increase of 10.28% [2]. Shareholder and Dividend Information - Since its A-share listing, China Chemical has distributed a total of 9.958 billion yuan in dividends, with 3.305 billion yuan paid out in the last three years [3]. - As of September 30, 2025, the number of shareholders increased to 111,200, up by 19.23%, while the average number of circulating shares per person decreased by 15.74% to 54,562 shares [2][3]. - The second-largest circulating shareholder, Hong Kong Central Clearing Limited, reduced its holdings by 11.2 million shares to 182 million shares [3].

Core Viewpoint - China Chemical's stock experienced a slight increase of 0.25% on November 11, with a trading volume of 609 million yuan, indicating stable market interest in the company [1] Financing Summary - On November 11, China Chemical had a financing buy-in amount of 78.54 million yuan, with a net financing buy of 885,700 yuan after repayments [1] - The total financing and securities balance reached 1.905 billion yuan, accounting for 3.86% of the circulating market value, which is below the 30th percentile level over the past year, indicating a low financing balance [1] - In terms of securities lending, 27,900 shares were repaid, with 6,000 shares sold, amounting to a selling value of 48,600 yuan, and a remaining securities lending balance of 25,680 yuan, also below the 10th percentile level over the past year [1] Financial Performance - As of September 30, China Chemical reported a total of 111,200 shareholders, an increase of 19.23% from the previous period, while the average circulating shares per person decreased by 15.74% to 54,562 shares [2] - For the period from January to September 2025, the company achieved a revenue of 136.3 billion yuan, reflecting a year-on-year growth of 1.15%, and a net profit attributable to shareholders of 4.232 billion yuan, which is a 10.28% increase year-on-year [2] Dividend Information - Since its A-share listing, China Chemical has distributed a total of 9.958 billion yuan in dividends, with 3.305 billion yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 182 million shares, a decrease of 112 million shares from the previous period [3] - China Securities Finance Corporation remains the seventh-largest circulating shareholder with 98.6542 million shares, unchanged from the previous period [3] - Huatai-PB CSI 300 ETF and E Fund CSI 300 ETF are also among the top ten circulating shareholders, with both experiencing a decrease in holdings [3]